Anti-Rheumatics Market PDF | Growth | Trends | Forecast to 2022-2027

1. Global Anti-Rheumatics Market Research and Forecast Report 2022- 2027 Author: Elena Anderson Marketing Manager Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group © 2022 IMARC All Rights Reserved

2. Report DescriptionAbout IMARC Group International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

3. Report Description and Highlights Report Description Global Anti-Rheumatics Market Research Report 2022-2027: According to the latest report by IMARC Group, titled “Anti-Rheumatics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," the global anti-rheumatics market reached a value of US$ 61.1 Billion in 2021. Rheumatoid arthritis is a chronic, autoimmune disease that affects the joints, articular tissues, and extra-articular organs. It is a progressive disorder that results in pain, inflammation, stiffness, and swelling of joints. Anti-rheumatics refer to drugs used to manage different symptoms of rheumatoid arthritis and modify the course of the disease. They can be administered subcutaneously (SC), orally, or intravenously (IV) into the body of the patient. Anti-rheumatics are also used to treat various types of cancer, and bowel, connective tissue, and autoimmune conditions, such as psoriatic arthritis, lupus, Sjogren syndrome (SS), systemic sclerosis (SSc), and systematic lupus erythematosus. Medical practitioners usually prescribe the drug to reduce pain, prevent bone deformity, reduce joint damage, preserve the structure and function of the joints, slow the progression of arthritis, and improve the person’s overall function. Request for a PDF sample of this report: https://www.imarcgroup.com/anti-rheumatics- market/requestsample

4. Report Description and Highlights Report Description Global Anti-Rheumatics Market Trends: The rising incidences of rheumatoid arthritis, especially among the steadily growing geriatric population, are creating a positive outlook for the market. Anti-rheumatic drugs are widely used to treat rheumatoid arthritis and inflammatory diseases that cause swelling in joints and damage the eyes, lungs and skin. In line with this, the increasing incidences of obesity due to unhealthy eating habits and changing lifestyles of the masses are further favoring the market growth. Apart from this, rapid technological advancements in the field of biosimilars and novel biologic therapies that act faster than conventional drugs and are provided in combination with the disease-modifying anti-rheumatic drug (DMARD) to patients are providing an impetus to the market growth. Moreover, the widespread adoption of prescription-based medications due to the increasing number of specialized hospitals worldwide is augmenting the market growth. Other factors, including the rising expenditure capacities of consumers, availability of early diagnosis and treatment options, and continuous research and development (R&D) activities to lower the side effects of the drug, are anticipated to drive the market toward growth. On account of the aforementioned factors, the market is anticipated to reach a value of US$ 72.1 Billion by 2027, growing at a CAGR of 2.74% during 2022-2027. View Report TOC, Figures and Tables: https://www.imarcgroup.com/anti-rheumatics-market

5. Report Description and Highlights Report Description Key Market Segmentation The research report includes the following segments: Breakup by Type: •Prescription-based Drugs •Over-the-Counter Drugs Breakup by Route of Drug Administration: •Oral •Parenteral •Others Breakup by Distribution Channel: •Hospital Pharmacies •Retail Pharmacies •E-Commerce

6. Report Description and Highlights Report Description Breakup by Drug Class: •Disease Modifying Anti-Rheumatics Drugs (DMARD's) •Nonsteroidal Anti-Inflammatory Drugs (NSAID's) •Corticosteroids •Uric Acid Drugs •Others Breakup by Region: •North America •Asia Pacific •Europe •Latin America •Middle East and Africa

7. Report Description and Highlights Report Description Competitive Landscape with Key Players: •AbbVie Inc. •Amgen Inc. •AstraZeneca plc •Biogen Inc. •Bristol-Myers Squibb Company •Celltrion Inc. •Eli Lilly and Company •F. Hoffmann-La Roche AG •Johnson & Johnsons •Pfizer Inc. •Sanofi SA.

8. Key Questions Answered in the Report Report Description 1. How has the global anti-rheumatics market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global anti-rheumatics market? What are the key regional markets? What is the breakup of the market based on the type? What is the breakup of the market based on the drug class? What is the breakup of the market based on the route of drug administration? What is the breakup of the market based on the distribution channel? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? 10. What is the structure of the global anti-rheumatics market and who are the key players? 11. What is the degree of competition in the industry? 2. 3. 4. 5. 6. 7. 8. 9.

9. Report DescriptionTable of Contents 1 Preface 2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Anti-Rheumatics Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast

10. Report DescriptionTable of Contents 6 Market Breakup by Type 6.1 Prescription-based Drugs 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Over-the-Counter Drugs 6.2.1 Market Trends 6.2.2 Market Forecast 7 Market Breakup by Drug Class 7.1 Disease Modifying Anti-Rheumatics Drugs (DMARD's) 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Nonsteroidal Anti-Inflammatory Drugs (NSAID's) 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Corticosteroids 7.3.1 Market Trends 7.3.2 Market Forecast Click here to visit the complete table of content with list of figures and tables: https://www.imarcgroup.com/anti-rheumatics-market/toc

11. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

12. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

13. Report Description and Highlights Report Description © 2022 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

14. Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com